Healthcare & Life Sciences
Weekly Roundup
Weekly Brief — Healthcare & Life Sciences
Strategic Health Expansion: Passage of Appropriation Act 2026 and Launch of Biopharma SHAKTI Framework
This report covers developments in Healthcare policy, Ayushman Bharat, and pharmaceuticals from March 16, 2026, to March 23, 2026. Brought to you by policyindex.ai. This intelligence highlights the formalization of the 2026 budget allocations, new digital health validation frameworks, and a pivot toward innovation-driven pharmaceutical manufacturing.
Key Statistics
| 840 Million+ | ₹10,721.89 Cr | 17,000+ |
|---|---|---|
| ABHA IDs Created to Date | Health Revenue Allocation (Appropriation Act) | Functional Jan Aushadhi Kendras |
Weekly Executive Summary
- Legislative Milestone: The President gave assent to the Appropriation Act, 2026, formalizing a revenue allocation of ₹10,721.89 Cr for the Department of Health and Family Welfare for the current fiscal cycle.
- Pharma Pivot: The Ministry of Science and Technology announced the Biopharma SHAKTI initiative, shifting the PLI focus from generic bulk drugs to high-value biologics and innovation-driven R&D.
- Digital Health Infrastructure: The National Health Authority (NHA) integrated the …
Download Full Intelligence Brief (PDF)
Sign in to your PolicyIndex account to download the complete executive-ready PDF report including all policy exhibits, data tables, and strategic recommendations.
Log In to Download PDF Brief →